IRIS - Res&Arch Institutional Research Information System - Research & Archive

TIACCI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.762
EU - Europa 1.662
AS - Asia 376
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 1
Totale 3.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.757
IT - Italia 575
IE - Irlanda 412
UA - Ucraina 237
HK - Hong Kong 151
SE - Svezia 132
VN - Vietnam 132
FI - Finlandia 84
RU - Federazione Russa 60
DE - Germania 54
CN - Cina 47
FR - Francia 26
GB - Regno Unito 26
TR - Turchia 23
BE - Belgio 17
CH - Svizzera 14
AT - Austria 8
IN - India 7
PL - Polonia 7
LB - Libano 5
GR - Grecia 4
UZ - Uzbekistan 4
EC - Ecuador 3
MX - Messico 3
BR - Brasile 2
CA - Canada 2
CI - Costa d'Avorio 2
ES - Italia 2
EU - Europa 2
IQ - Iraq 2
NL - Olanda 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
Totale 3.811
Salva come PNG Salva come JPEG
Città #
Dublin 412
Chandler 410
Perugia 267
San Mateo 218
Hong Kong 151
Dong Ket 132
Jacksonville 109
Altamura 95
Medford 91
Princeton 89
Ann Arbor 77
Lawrence 73
Wilmington 63
Andover 60
Des Moines 41
Beijing 36
Saint Petersburg 25
Izmir 23
Rome 23
Helsinki 22
Redmond 22
Norwalk 19
Brussels 17
Woodbridge 17
New York 14
Los Angeles 12
San Paolo di Civitate 12
Ashburn 10
Redwood City 10
Terni 10
Houston 8
Moscow 7
Falls Church 6
Foligno 5
Boardman 4
Chicago 4
Duncan 4
Frankfurt am Main 4
Lausanne 4
Verona 4
Dearborn 3
Gradara 3
Hyderabad 3
Kraków 3
Prata Di Pordenone 3
Scafa 3
Shanghai 3
Abidjan 2
Bacoli 2
Brasília 2
Collazzone 2
Cornedo Vicentino 2
Den Haag 2
Geneva 2
Guangzhou 2
Guayaquil 2
Ivrea 2
Lappeenranta 2
Madrid 2
Mexico City 2
Nanning 2
Oxford 2
Paris 2
Parma 2
San Diego 2
Tappahannock 2
Allentown 1
Auburn Hills 1
Belgioioso 1
Bologna 1
Boydton 1
Cambridge 1
Collegeville 1
Dallas 1
Faenza 1
Fairburn 1
Falkenstein 1
Frankfurt Am Main 1
Fremont 1
Hangzhou 1
Kagoya 1
London 1
Melbourne 1
Milan 1
Montignoso 1
Montreal 1
Mumbai 1
Nanjing 1
Ottawa 1
Phoenix 1
Pisa 1
Quito 1
Salford 1
San Giuliano Milanese 1
Serio 1
Todi 1
Tong 1
Valle 1
Vienna 1
Wayne 1
Totale 2.703
Salva come PNG Salva come JPEG
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 97
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 89
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 86
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 85
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 78
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 78
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 74
Genomics of Hairy cell leukemia 72
A microRNA signature specific for hairy cell leukemia and associated with modulation of the MAPK-JNK pathways. 67
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 67
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 65
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 65
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 62
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 60
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 60
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 60
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 59
Aspects of gene expression in B cell lymphomas 59
Improved achiral and chiral hplc-uv analysis of ruxolitinib in two different drug formulations 59
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 58
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 57
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. 57
BRAF mutations in hairy-cell leukemia. 57
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 57
Primary Burkitt's lymphoma of bladder in patient with AIDS. 55
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 53
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 53
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 52
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 50
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 49
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis. 48
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 48
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. 48
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 48
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 47
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 47
Hairy Cell Leukemia Biomarkers and Methods of Using Same 46
The authors reply 46
ALK signaling and target therapy in anaplastic large cell lymphoma 46
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 45
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. 44
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications 44
New treatment options in hairy cell leukemia with focus on BRAF inhibitors 44
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 43
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. 43
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression 43
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemia. 42
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 42
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin 41
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 41
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 41
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 41
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 41
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. 40
The genetics of nodal marginal zone lymphoma 40
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 39
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 38
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 37
Lymphoma 36
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 34
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 34
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 33
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues. 33
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. 33
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia 33
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 32
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 31
Transformation of IGHV4-34+ hairy cell leukaemia-variant with U2AF1 mutation into a clonally-related high grade B-cell lymphoma responding to immunochemotherapy 31
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas [Tiacci and Lazzi are co-senior authors] 31
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. 30
The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma 30
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. 29
Hairy cell leukaemia mimicking multiple myeloma 29
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 29
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 29
Gene dosage effects in chronic lymphocytic leukemia. 28
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors 28
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 27
Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. 26
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 24
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 23
[Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma] 23
SAVI: a statistical algorithm for variant frequency identification. 21
Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells 21
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 19
Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma. [Tiacci, Mecucci and Kueppers are co-senior authors] 19
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 17
Anaplastic large-cell lymphoma 16
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 15
Overlapping features of therapy-related and de novoNPM1-mutated AML 13
Vemurafenib and rituximab in patients with hairy cell leukemia previously treated with moxetumomab pasudotox 12
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines 11
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects 11
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 10
Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia 10
Genetics of classical Hodgkin Lymphoma [Educational Program of the 23th Congress of the European Hematology Association] 9
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 8
One disease, two faces: clonally-related AML and MPDCP with skin involvement 8
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement 8
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma 7
Totale 4.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201937 0 0 0 0 0 0 0 0 0 4 31 2
2019/2020286 10 6 28 4 31 7 38 7 42 87 10 16
2020/2021716 7 40 14 42 191 36 33 43 102 22 48 138
2021/2022925 16 155 4 21 24 8 12 233 59 71 197 125
2022/20231.412 97 268 17 115 101 146 4 49 522 37 43 13
2023/2024360 35 41 43 13 8 9 140 3 51 17 0 0
Totale 4.128